Clinical Trial Update: Budesonide 9 mg Capsules in Active UC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating budesonide 9 mg capsules for active ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Colitis, Ulcerative | Phase 2 | Status: COMPLETED